Govt Job for Pharmacists in Zilla Parishad

As the number of patients under C-19 has increased in Satara district, the following vacancies have been filled on contract and temporary basis in DCHC / DCH / CCC will be filled in the method.

Post : Pharmacist

Qualification : D.Pharm, B.Pharm, M.Pharm
Salary : Rs.17,000/- pm

Interested candidates should be present at Yashwantrao Chavan Hall, Zilla Parishad, Satara along with the required original documents as mentioned below date from 11.00 am to 01.00 am.  Subsequent candidates will not be considered.
Date : 12th May, 2021 (Wednesday)

• Candidates should take careful precaution before filling up the priority of talukas, no change will be made in any situation after receiving the appointment order and no recommendation letter for transfer should be submitted by any office bearer Or do not apply.  Candidates should also not ask employees for personal appointments by telephone.  Candidates will be contacted through the office after the appointment order is issued.

• Under C-19 taluka wise DCHC / DCH / CCC in which contract orders will be issued to the candidates on the list as per the requirement of staff nurses.

• Merit quality list of all eligible / ineligible candidates for the above posts according to higher educational qualification will be prepared and published on the website of Satara Zilla Parishad, Satara office.

• Candidates should check the list on the website from time to time.  No candidate should visit Zilla Parishad, Satara frequently to get contract appointment.  Otherwise, the appointment will not be made on the understanding that the rules were violated during the outbreak of C-19.

Related Posts

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

New Delhi: Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research and development activities with the business representatives of the pharmaceutical industry. “Had…

Senores Pharma to Buy Two Teva ANDAs

Mumbai, August 14, 2025 — Senores Pharmaceuticals will acquire two abbreviated new drug applications (ANDAs) from Teva Pharmaceuticals USA. The deal is Senores’ third US move in six months, underscoring…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Senores Pharma to Buy Two Teva ANDAs

Senores Pharma to Buy Two Teva ANDAs

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lilly launches Mounjaro KwikPen in India

Lilly launches Mounjaro KwikPen in India